Clinical Trials Insight: 700043056
Latest Information Update: 06 Apr 2009
At a glance
- Drugs MDX 1342 (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Sponsors Medarex
Most Recent Events
- 06 Apr 2009 New trial record.